“…In 1982, Levin et al first described the case of cisplatin-induced hyponatremia in a patient with malignant thymoma. Subsequently, it has been reported in patients with ovarian cancer, non-small cell lung cancer, esophageal cancer, cervical neuroendocrine tumor, squamous cell carcinoma, pediatric osteosarcoma, and urothelial carcinoma [3]. To the best of our knowledge, it is the first case of cisplatin-induced hyponatremia in a patient with squamous cell carcinoma of the base of the tongue.…”